Extended regulatory certainty through 2027: Current 7.93% rate of return (10.06% ROE) locked in for an additional year, providing enhanced earnings visibility and reducing near-term regulatory uncertainty for investors Reduced regulatory execution risk: One-year deferral of cost of capital filing to May 2027 eliminates regulatory proceedings and associated legal/consulting expenses in 2026,…

Our analysis rates this filing BULLISH. This filing represents a materially positive development for the company. The one-year deferral of the cost of capital application extends regulatory certainty and locks in favorable economics (10.06% ROE, 7.93% overall return) through 2027 instead of 2026.…

Concern level: LOW (2.0/10).

Notable risk changes: Regulatory certainty extended: Current 7.93% rate of return (10.06% ROE) locked in through December 31, 2027 instead of 2026 - provides earnings visibility and reduces near-term regulatory risk; Cost of capital filing deferred by one year to May 1, 2027 - reduces regulatory execution risk and legal/consulting expenses in 2026, allows focus on operational performance; CPUC approval demonstrates…

The model predicts AWR will underperform the S&P 500 by about 0.1% over 30 days (model confidence 85%). This is model analysis for research, not investment advice.